Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01999881 · ClinicalTrials.gov registry record · NA
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01999881 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 21 participants.
The verdict
NCT01999881, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies exercise intervention in improving quality of life and exercise capacity and reducing inflammation and oxidative stress in patients with lung cancer and their support persons. Exercise therapy may help improve quality of life, may increase exercise capacity, and may reduce inflammation and oxidative stress in patients with lung cancer and their supporters.
Interventions
- OTHER laboratory biomarker analysis
- PROCEDURE quality-of-life assessment
- BEHAVIORAL exercise intervention
- PROCEDURE standard follow-up care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01999881
The ClinicalTrials.gov registry entry for NCT01999881 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT01999881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01999881 about?
NCT01999881 is a clinical study titled "Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients". This randomized pilot clinical trial studies exercise intervention in improving quality of life and exercise capacity and reducing inflammation and oxidative stress in patients with lung cancer and their support persons. Exercise therapy may help improve quality of life, may increase exercise capaci...
What is the current status of trial NCT01999881?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2013-12. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01999881?
The interventions under investigation include: laboratory biomarker analysis (OTHER), quality-of-life assessment (PROCEDURE), exercise intervention (BEHAVIORAL), standard follow-up care (PROCEDURE).
Who is sponsoring clinical trial NCT01999881?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.